Quantitative trait loci influencing low density lipoprotein particle size in African Americans

Journal of Lipid Research

Volumn 47, Issue 7, 2006, Pages 1457-1462

  Kullo, Iftikhar J ^a   Ding, Keyue ^a   Boerwinkle, Eric ^b   Turner, Stephen T ^a   De Andrade, Mariza ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Bivariate; Genetic linkage; High density lipoprotein cholesterol; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; AUTOSOME; CHROMOSOME 12; CHROMOSOME 19; CHROMOSOME 4; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC CORRELATION; GENOMIC FRAGMENT; GENOTYPE; HERITABILITY; HUMAN; ISCHEMIC HEART DISEASE; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PARTICLE SIZE; PLEIOTROPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; LINKAGE (GENETICS); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; QUANTITATIVE TRAIT LOCI; TRIGLYCERIDES;

EID: 33746069059     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600078-JLR200     Document Type: Article

References (43)

1. Freedman, D. S., J. D. Otvos, E. J. Jeyarajah, J. J. Barboriak, A. J. Anderson, and J. A. Walker. 1998. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18: 1046-1053.
2. Kuller, L., A. Arnold, R. Tracy, J. Otvos, G. Burke, B. Psaty, D. Siscovick, D. S. Freedman, and R. Kronmal. 2002. Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 22: 1175-1180.
3. Blake, G. J., J. D. Otvos, N. Rifai, and P. M. Ridker. 2002. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 106: 1930-1937.
4. Carmena, R., P. Duriez, and J. C. Fruchart. 2004. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 109: III2-III7.
5. Austin, M. A., J. D. Brunzell, W. L. Fitch, and R. M. Krauss. 1990. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis. 10: 520-530.
6. Reaven, G. M., Y. D. Chen, J. Jeppesen, P. Maheux, and R. M. Krauss. 1993. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J. Clin. Invest. 92: 141-146.
7. Bosse, Y., L. Perusse, and M. C. Vohl. 2004. Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations. J. Lipid Res. 45: 1008-1026.
8. Jain, T., R. Peshock, D. K. McGuire, D. Willett, Z. Yu, G. L. Vega, R. Guerra, H. H. Hobbs, and S. M. Grundy. 2004. African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J. Am. Coll. Cardiol. 44: 1011-1017.
9. Haffner, S. M., R. D'Agostino, Jr., D. Goff, B. Howard, A. Festa, M. F. Saad, and L. Mykkanen. 1999. LDL size in African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Arterioscler. Thromb. Vasc. Biol. 19: 2234-2240.
10. Kullo, I. J., M. de Andrade, E. Boerwinkle, J. P. McConnell, S. L. Kardia, and S. T. Turner. 2005. Pleiotropic genetic effects contribute to the correlation between HDL cholesterol, triglycerides, and LDL particle size in hypertensive sibships. Am. J. Hypertens. 18: 99-103.
11. Edwards, K. L., M. C. Mahaney, A. G. Motulsky, and M. A. Austin. 1999. Pleiotropic genetic effects on LDL size, plasma triglyceride, and HDL cholesterol in families. Arterioscler. Thromb. Vasc. Biol. 19: 2456-2464.
12. Pajukanta, P., H. E. Lilja, J. S. Sinsheimer, R. M. Cantor, A. J. Lusis, M. Gentile, X. J. Duan, A. Soro-Paavonen, J. Naukkarinen, J. Saarela, et al. 2004. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat. Genet. 36: 371-376.
13. The FBPP Investigators. 2002. Multi-center genetic study of hypertension: the Family Blood Pressure Program (FBPP). Hypertension. 39: 3-9.
14. O'Meara, J. G., S. L. Kardia, J. J. Armon, C. A. Brown, E. Boerwinkle, and S. T. Turner. 2004. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch. Intern. Med. 164: 1313-1318.
15. Kottke, B. A., P. P. Moll, V. V. Michels, and W. H. Weidman. 1991. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin. Proc. 66: 1198-1208.
16. Hoefner, D. M., S. D. Hodel, J. F. O'Brien, E. L. Branum, D. Sun, I. Meissner, and J. P. McConnell. 2001. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin. Chem. 47: 266-274.
17. Kullo, I. J., S. T. Turner, E. Boerwinkle, S. L. Kardia, and M. de Andrade. 2005. A novel quantitative trait locus on chromosome 1 with pleiotropic effects on HDL-cholesterol and LDL particle size in hypertensive sibships. Am. J. Hypertens. 18: 1084-1090.
18. Lange, K., and T. M. Goradia. 1987. An algorithm for automatic genotype elimination. Am. J. Hum. Genet. 40: 250-256.
19. O'Connell, J. R., and D. E. Weeks. 1998. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am. J. Hum. Genet. 63: 259-266.
20. de Andrade, M., B. Fridley, E. Boerwinkle, and S. T. Turner. 2003. Diagnostic tools in linkage analysis for quantitative traits. Genet. Epidemiol. 24: 302-308.
21. Lange, K., and M. Boehnke. 1983. Extensions to pedigree analysis. IV. Covariance components models for multivariate traits. Am. J. Med. Genet. 14: 513-524.
22. Jaquish, C. E., M. C. Mahaney, J. Blangero, S. M. Haffner, M. P. Stern, and J. W. MacCluer. 1996. Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans. Atherosclerosis. 122: 117-125.
23. Amos, C. I. 1994. Robust variance-components approach for assessing genetic linkage in pedigrees. Am. J. Hum. Genet. 54: 535-543.
24. de Andrade, M., T. J. Thiel, L. Yu, and C. I. Amos. 1997. Assessing linkage on chromosome 5 using components of variance approach: univariate versus multivariate. Genet. Epidemiol. 14: 773-778.
25. Sobel, E., H. Sengul, and D. E. Weeks. 2001. Multipoint estimation of identity-by-descent probabilities at arbitrary positions among marker loci on general pedigrees. Hum. Hered. 52: 121-131.
26. Self, S., and K-Y. Liang. 1987. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under non-standard conditions. J. Am. Stat. Assoc. 82: 605-610.
27. Morton, N. E. 1998. Significance levels in complex inheritance. Am. J. Hum. Genet. 62: 690-697.
28. Lamon-Fava, S., D. Jimenez, J. C. Christian, R. R. Fabsitz, T. Reed, D. Carmelli, W. P. Castelli, J. M. Ordovas, P. W. Wilson, and E. J. Schaefer. 1991. The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). Atherosclerosis. 91: 97-106.
29. Austin, M. A., B. Newman, J. V. Selby, K. Edwards, E. J. Mayer, and R. M. Krauss. 1993. Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis. Arterioscler. Thromb. 13: 687-695.
30. Bosse, Y., M. C. Vohl, J. P. Despres, B. Lamarche, T. Rice, D. C. Rao, C. Bouchard, and L. Perusse. 2003. Heritability of LDL peak particle diameter in the Quebec Family Study. Genet. Epidemiol. 25: 375-381.
31. Barzilai, N., G. Atzmon, C. Schechter, E. J. Schaefer, A. L. Cupples, R. Lipton, S. Cheng, and A. R. Shuldiner. 2003. Unique lipoprotein phenotype and genotype associated with exceptional longevity. J. Am. Med. Assoc. 290: 2030-2040.
32. Rainwater, D. L., L. Almasy, J. Blangero, S. A. Cole, J. L. VandeBerg, J. W. MacCluer, and J. E. Hixson. 1999. A genome search identifies major quantitative trait loci on human chromosomes 3 and 4 that influence cholesterol concentrations in small LDL particles. Arterioscler. Thromb. Vasc. Biol. 19: 777-783.
33. Austin, M. A., K. L. Edwards, S. A. Monks, K. M. Koprowicz, J. D. Brunzell, A. G. Motulsky, M. C. Mahaney, and J. E. Hixson. 2003. Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia. J. Lipid Res. 44: 2161-2168.
34. Allayee, H., K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. de Bruin, and A. J. Lusis. 2000. Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. J. Lipid Res. 41: 245-252.
35. Turner, S. T., S. L. Kardia, E. Boerwinkle, and M. de Andrade. 2004. Multivariate linkage analysis of blood pressure and body mass index. Genet. Epidemiol. 27: 64-73.
36. Calvano, S. E., W. Xiao, D. R. Richards, R. M. Felciano, H. V. Baker, R. J. Cho, R. O. Chen, B. H. Brownstein, J. P. Cobb, S. K. Tschoeke, et al. 2005. A network-based analysis of systemic inflammation in humans. Nature. 437: 1032-1037.
37. Rotter, J. I., X. Bu, R. M. Cantor, C. H. Warden, J. Brown, R. J. Gray, P. J. Blanche, R. M. Krauss, and A. J. Lusis. 1996. Multilocus genetic determinants of LDL particle size in coronary artery disease families. Am. J. Hum. Genet. 58: 585-594.
38. Tatton, L., G. M. Morley, R. Chopra, and A. Khwaja. 2003. The Src-selective kinase inhibitor PP1 also inhibits Kit and Bcr-Abl tyrosine kinases. J. Biol. Chem. 278: 4847-4853.
39. Heinrich, M. C., D. C. Dooley, and W. W. Keeble. 1995. Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 85: 1769-1780.
40. Kolbus, A., M. Blazquez-Domingo, S. Carotta, W. Bakker, S. Luedemann, M. von Lindern, P. Steinlein, and H. Beug. 2003. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood. 102: 3136-3146.
41. Allayee, H., B. E. Aouizerat, R. M. Cantor, G. M. Dallinga-Thie, R. M. Krauss, C. D. Lanning, J. I. Rotter, A. J. Lusis, and T. W. de Bruin. 1998. Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet. 63: 577-585.
42. Bosse, Y., L. Perusse, J.P. Despres, B. Lamarche, Y. C. Chagnon, T. Rice, D. C. Rao, C. Bouchard, and M. C. Vohl. 2003. Evidence for a major quantitative trait locus on chromosome 17q21 affecting low-density lipoprotein peak particle diameter. Circulation. 107: 2361-2368.
43. Badzioch, M. D., R. P. Igo, Jr., F. Gagnon, J. D. Brunzell, R. M. Krauss, A. G. Motulsky, E. M. Wijsman, and G. P. Jarvik. 2004. Low-density lipoprotein particle size loci in familial combined hyperlipidemia: evidence for multiple loci from a genome scan. Arterioscler. Thromb. Vasc. Biol. 24: 1942-1950.